Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
An exploratory study of venetoclax in combination with bortezomib-cyclophosphamide-dexamethasone (VCD) induction therapy in newly diagnosed transplant eligible (NDTE MM) multiple myeloma with proteomic correlative studies.
Spencer, Andrew
(Primary Chief Investigator (PCI))
Kennedy, Nola
(Project Manager)
Mollee, Peter N.
(Chief Investigator (CI))
Harrison, Simon James
(Chief Investigator (CI))
Quach, Hang
(Chief Investigator (CI))
Ho, Phoebe Joy
(Chief Investigator (CI))
Australian Centre for Blood Diseases
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
27/09/18
→
27/09/23
View all
View less
Clinical Trial Phase
Phase II